BackBrainstorm Cell Therapeutics Overview

Brainstorm Cell Therapeutics Net Income

Profitability analysis for BCLI.

Quarterly Net Income

$2.13M
174.27% YoY

As of Mar 2026

Annual Net Income (TTM)

$15.30M
237.99% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...